Precision glycocalyx editing as a strategy for cancer immunotherapy.
about
Cutting back on the carbsRole of Natural Killer Cells in HIV-Associated Malignancies.Marine Lectins DlFBL and HddSBL Fused with Soluble Coxsackie-Adenovirus Receptor Facilitate Adenovirus Infection in Cancer Cells BUT Have Different Effects on Cell SurvivalChemical Synthesis and Evaluation of a Disialic Acid-Containing Dextran Polymer as an Inhibitor for the Interaction between Siglec 7 and Its Ligand.Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property.Tumor antigen glycosaminoglycan modification regulates antibody-drug conjugate delivery and cytotoxicity.Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease.Engineering and physical sciences in oncology: challenges and opportunities.Judging a tumor cell by its cover: a matter of mitochondrial contact sites.Enzymes as Immunotherapeutics.Tailoring Natural Killer cell immunotherapy to the tumour microenvironment.Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1.Patterns and levels of platelet glycosylation in patients with coronary heart disease and type 2 diabetes mellitus.Isotope-targeted glycoproteomics (IsoTaG) analysis of sialylated N- and O-glycopeptides on an Orbitrap Fusion Tribrid using azido and alkynyl sugars.Site-Specific Antibody Functionalization Using Tetrazine-Styrene Cycloaddition.Genetically Encoded Toolbox for Glycocalyx Engineering: Tunable Control of Cell Adhesion, Survival, and Cancer Cell Behaviors.Sialic Acid Metabolism: A Key Player in Breast Cancer Metastasis Revealed by Metabolomics.Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities.O-linked mucin-type glycosylation in breast cancerProgrammed cell removal by calreticulin in tissue homeostasis and cancer
P2860
Q37264076-C42F2BF8-6A55-486A-BA16-AEBC3A90AF4FQ37712593-C45DFA3F-82A8-4E96-89B4-A2EC28DCF473Q37721826-2CC1E427-6DD3-456F-B5EA-A76B7A1052E8Q38856537-D979D090-C787-4B77-9CA9-8F51911EAA74Q41097112-2DC0E9BB-11B2-424B-9AD6-65C03447E887Q41817072-1CF4FE1A-3A5F-40D6-B821-2FCEE5D46C4CQ47220975-73019EF2-C2D7-447B-B563-F03B152DF657Q47244877-D30D7FE3-5EC6-4625-B9AE-23986A3B969EQ48114246-8D4C0CFB-97BD-4A87-859D-23B84A8FEE0DQ48333043-CE495B48-F3A7-4335-BEFA-CAF2B8546CD9Q49956252-710493FB-EF37-48A0-BBEC-79706C46A012Q50040421-815A2517-A871-46B2-B1C5-A321B78994FCQ50070058-04740CC2-0EF2-49DC-875D-44385BB3FF06Q50231541-8EBF63F6-5948-4C31-A6AE-AF47069B3959Q52691844-1668BC4E-4AD4-4BAF-A87B-22F769797989Q54977954-F97963A5-6186-4DEB-BBDA-49944CD3BE3FQ55318147-AB151226-B89A-4A10-84DC-CC8E5B4193EFQ55515607-D7EBA2D2-A853-487E-A871-0658794918D7Q57107715-CD0BEB3D-D027-49FD-A4BC-0AA577FA168CQ58790947-6A86D3C0-B905-4F26-AA62-FE8A7100B2B5
P2860
Precision glycocalyx editing as a strategy for cancer immunotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Precision glycocalyx editing as a strategy for cancer immunotherapy.
@en
Precision glycocalyx editing as a strategy for cancer immunotherapy.
@nl
type
label
Precision glycocalyx editing as a strategy for cancer immunotherapy.
@en
Precision glycocalyx editing as a strategy for cancer immunotherapy.
@nl
prefLabel
Precision glycocalyx editing as a strategy for cancer immunotherapy.
@en
Precision glycocalyx editing as a strategy for cancer immunotherapy.
@nl
P2093
P2860
P356
P1476
Precision glycocalyx editing as a strategy for cancer immunotherapy
@en
P2093
Carolyn R Bertozzi
Elliot C Woods
Petar Vukojicic
P2860
P304
10304-10309
P356
10.1073/PNAS.1608069113
P407
P50
P577
2016-08-22T00:00:00Z